Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Airbus CFO says EU antitrust talks on satellite merger are constructive but not concluded

Airbus CFO says EU antitrust talks on satellite merger are constructive but not concluded

ReutersReuters2026/10/28 19:21

By Florence Loeve, Gianluca Lo Nostro and Joanna Plucinska

- Airbus' CFO on Wednesday said that discussions with European antitrust authorities on a planned merger of the satellite businesses of the European aerospace group with Italy's Leonardo and France's Thales ones were constructive but had not yet been concluded.

Airbus, Italy's Leonardo and France's Thales announced plans in 2025 to combine their satellite manufacturing activities into a standalone company. The aerospace and defense groups want to create a European champion able to compete with Elon Musk's Space X and Chinese rivals.

The project aims at creating the new joint company at the end of 2027, but it needs to get a greenlight from the EU's competition authority.

Airbus CFO Thomas Toepfer, speaking during a call with analysts, said the company still aimed to sign a definitive agreement in 2026 to then close the transaction in 2027, though he said that the group did not fully control the timing due to the antitrust process.

"Not everything is fully under our control, but we remain positive", he said.


(Reporting by Florence Loève, Gianluca Lo Nostro)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit

An analysis of insurance claims data found that if GLP-1 drugs used for weight loss and diabetes are priced below $350 per month, payers—such as employers and plan sponsors—would achieve net savings due to a decrease in related healthcare service utilization.

智通财经•2026/11/15 04:01
From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit

UNI falls below $5

金色财经•2026/11/15 03:37
UNI falls below $5